Serving Size: 2 Capsules
Amount Per Serving
LIFENOL® Hops extract† (15-25:1) … 120 mg
Calcium D-Glucarate … 150mg
DIM (3,3'-Diindolylmethane) … 108 mg
Choline (bitartrate) … 27.6 mg
Non-medicinal ingredients: broccoli extract* (300 mg), microcrystalline cellulose, maltodextrin, silica. Capsule: hypromellose. †LIFENOL® is a registered trademark of Naturex, Inc. *Produced under patent US2006/010032 licensed from Caudill Seed Inc.
AOR Guarantees: that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, nuts, peanuts, sesame seeds, sulphites, mustard, dairy, soy, eggs, fish, shellfish or any animal byproduct.
Source: LIFENOL® Hops extract; Pharmaceutical synthesis;
What Is It?
Estro Adapt includes some of the most important estrogen-modulating nutrients known to support healthy estrogen metabolism and detoxification. Such ingredients include D-Glucarate, DIM (3,3'-diindolylmethane), hops extract, choline and sulforaphane glucosinolate from broccoli extract. Both toxins and unbalanced estrogen metabolism are believed to increase the risk of women's cancers.
What Does It Do?Primary Uses: Estro Adapt reduces the risk of abnormal cellular growth related to estrogen via various mechanisms. Estro Adapt supports the production of “good” estrogens over “bad” estrogens thanks to DIM, a metabolite of I-3-C. DIM also supports healthy cervical tissue growth. 8PN is a phytoestrogen found in hops shown to reduce abnormal cell growth in breast tissue and interfere with undesirable estrogenic activity. D-glucarate, choline and SGS all support the elimination of toxins and excess or inactivated hormones.Secondary Uses: Estro Adapt may also support healthy, regular menstruation due to its estrogen-modulating activities.
Who Should Take It?
Those concerned with the effects of excessive estrogen, environmental toxicity, and women looking for natural support for healthy and regular menstrual cycles.
In a 30-day study, DIM-treated women showed a significant increase in levels of 2-OHE1 (“good” estrogen), DIM and cortisol, and a non-significant increase of 47% in the 2-OHE1/16 α -OHE1 ratio from 1.46 to 2.14 compared to the placebo group. In this pilot study, DIM increased the production of “good” estrogen over “bad” estrogen, which has a protective effect. (Dalessandri et al., 2004)
Take 2 capsules daily with breakfast, or as directed by a qualified health care practitioner.
Abou-Issa H, Moeschberger M, el-Masry W, Tejwani S, Curley RW Jr, Webb TE. Relative efficacy of glucarate on the initiation and promotion phases of rat mammary carcinogenesis. Anticancer Res 1995 May-Jun; 15(3): 805-10.
Bradlow HL, Telang NT, Sepkovic DW, Osborne MP. “
2-hydroxyestrone: the ‘good' estrogen.”
J Endocrinol. 1996 Sep; 150 Suppl: S259-65.
Calcium D-Glucarate Monograph. Alternative Medicine Reviews. 2002. 7(4): 336-339.
Dalessandri KM, Firestone GL, Fitch MD, Bradlow HL and Bjeldanes LF. Pilot Study: Effect of 3,3'-Diindolylmethane Supplements on Urinary Hormone Metabolites in Postmenopausal Women with a History of Early-Stage Breast Cancer. Nutrition and Cancer, 50(2), 161–167.
Heerdt AS, Young CW, Borgen PI. Calcium glucarate as a chemopreventive agent in breast cancer. Isr J Med Sci 1995;31:101-105.
Hong C, Kim HA, Firestone GL and Bjeldanes LF. 3,3′-Diindolylmethane (DIM) induces a G1 cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21WAF1/CIP1 expression. Carcinogenesis, Vol. 23, No. 8, 1297-1305, August 2002.
Miligan SR, Kalita JC, Pocock V, Van de Kauter V, Stevens JF, Deinzer ML, Rong H and De Keukeleire D. The endocrine activities of 8-prenylnaringenin and related hop (Humulus lupulus L.) flavonoids. The Journal of Clinical Endocrinology & Metabolism. 2000; 85(12): 4912-4915.
Muti P, Bradlow HL, Micheli A, Krogh V, Freudenheim JL, Schunemann HJ, Stanulla M, Yang J, Sepkovic DW, Trevisan M and Berrino F. Estrogen Metabolism and Risk of Breast Cancer: A Prospective Study of the 2:16 α -Hydroxyestrone Ratio in Premenopausal and Postmenopausal Women. Epidemiology, Vol. 11, No. 6 (Nov., 2000), pp. 635-640.
Pepper MS, Hazel SJ, HÜmpel M, Schleuning WD. 8-prenylnaringenin, a novel phytoestrogen, inhibits angiogenesis in vitro and in vivo. Journal of Cellular Physiology. 2003; 99(1): 98 – 107.
Ramirez MC and Singletary KW. Regulation of Estrogen Receptor Alpha Expression in Breast Cancer Cells by Sulforaphane. The FASEB Journal. 2008;22:311.6.
Zeligs MA, Sepkovic DW, Manrique C, Macsalka M, Williams DE and Bradlow HL. Absorption-enhanced 3,3'-Diindolylmethane: Human Use in HPV-related, Benign and Pre-cancerous Conditions. Proc. Am. Assoc. Cancer Res. 2003, Apr; 44.
Canada and USA
Disclaimer: This content is subject to change. The information is intended to inform and educate; it does not replace the medical evaluation, advice, diagnosis or treatment by a healthcare professional. www.nhpassist.com © 2014 NDAssist Inc. and/or its affiliates. All rights reserved.